Key points are not available for this paper at this time.
-susceptibility disease variants will permit, at a given moment, offering of therapies to patients according to their genotype.
Bosque‐Plata et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: